… In another trial in 15 patients with stage IIIc or IV melanoma, meaningful objective clinical
responses were observed, including two complete remissions, two partial remissions, and four …

… Dendritic cells (DCs)-based vaccines are generated by the selection of CD14+ monocytes
from isolated PBMC. Monocytes are cultured with granulocyte-macrophage colony-…

… generation of DC vaccines. The randomized … , colorectal cancer, renal cell carcinoma, and
breast cancer13. DC-CIK treatment shows significantly enhanced response rate in patients, …

… Most metastatic colorectal cancer patients develop brain … of an autologous tumor lysate-pulsed
dendritic cell vaccine to … survivin to vaccinate melanoma patients in a phase II study, …

… increased CLX's antitumor efficacy in the C26 colorectal cancer model [39]. Based on our …
-vivo dendritic cell vaccine, we collected mouse bone marrow according to our previous study […

… We also showed that the addition of dendritic cells (DC) to CIK therapy, common … advanced
colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell …

… to the ex vivo dendritic cells from the patients of melanoma induced strong cancer immunity
[79]; … The same vaccine also failed in another phase III clinical trial in 1345 MAGE-A3-positive …

… lysates, peptide vaccines, dendritic cell vaccines), stromal … metastatic melanoma, colorectal
cancer, and renal cell … -limited peptides for treating advanced colorectal cancer subjected in …

… -tumor performance of the tumor lysate-pulsed DC-based vaccine in mice carrying CT26/4T1
tumors… ) and CT26 (colorectal carcinoma) were obtained from the Pasteur Institute (Tehran, …

… Dendritic cell (DC) based vaccines have shown some … dendritic cell plus best supportive
care compared with best supportive care in pre-treated advanced colorectal cancer patients. …